Market Overview

UPDATE: JP Morgan Upgrades Aetna to Overweight on Revised Numbers Post Deal Closure

Share:
Related AET
Infrastructure, Immigration And 7 Key Takeaways From Trump's Address To Congress
Ionis Shares Pop As Aetna Adds Spinraza To Precertification List
High stakes for healthcare vote (Seeking Alpha)

JP Morgan raised its rating on Aetna (NYSE: AET) from Neutral to Overweight and increased its price target from $46 to $52.

JP Morgan said, "We are upgrading Aetna to Overweight from Neutral and raising our price target from $46 to $52 on the expectation of upwardly revised numbers post CVH deal closing, AET's below-average reform exposure and most importantly an increasing recognition of the company's ACO positioning. From a catalyst perspective, at next Wednesday's investor day we expect initial 2013 EPS guidance in the $5.40 range (JPM $5.40, consensus $5.51), within the range of investor expectations."

Aetna closed at $43.43 on Thursday.

Latest Ratings for AET

DateFirmActionFromTo
Jan 2017Leerink SwannDowngradesOutperformMarket Perform
Jan 2017PiperJaffrayInitiates Coverage OnNeutral
Nov 2016Credit SuisseUpgradesNeutralOutperform

View More Analyst Ratings for AET
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Upgrades Pre-Market Outlook Analyst Ratings

 

Related Articles (AET)

View Comments and Join the Discussion!